Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials is a research paper published in Clinical Trials (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: CA180819
National Institutes of Health
Grant: CA180888
NCI NIH HHS
Grant: U10 CA180819
NCI NIH HHS
Grant: U10 CA180888
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords